We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
CTGrade rh IL-6
CTGrade rh IL-6 is a recombinant human protein that is produced from E. coli and is designed to support basic, translational, and clinical research, as well as commercial applications, and offers:
- High biological activity verified by a relevant bioactivity assay
- Low endotoxin levels
- ≥ 97% purity
- High lot-to-lot consistency
Size: 50 µg, 100 µg, and 1 mg. Custom sizes and packaging available on request.
IL-6 is an important pro-inflammatory and anti-inflammatory cytokine expressed by T cells, macrophages, and muscle cells.
- Signals through a receptor complex containing two receptors, IL-6Rα and gp130
- Plays an important function in promoting fever and can serve to stimulate an immune response to trauma. IL-6 is often used for growth of hybridoma cell lines
The biological activity of CTGrade interleukins and growth factors is standardized, where applicable, to WHO International standards, providing cell and gene therapy developers consistent, lot-to-lot biological activity and performance.
The CTGrade products are manufactured in a facility that does not use or process beta- lactam containing materials. No animal- or human-derived materials were used during manufacturing or as ingredients. These products are manufactured, tested, and released in an ISO 9001:2015 certified facility following cGMP practices. USP chapter <1043> for ancillary materials has been considered in the manufacture of these products.
SDS-PAGE Showing a Single Prominent Band at 20.9 kDa


Figure 1. CTGrade rh IL-6 (1 μg) was resolved with SDS-PAGE under non-reducing (NR) conditions and visualized by InstantBlue staining showing a single prominent band at 20.9 kDa.
Cell-Based Proliferation Assay


Figure 2. The biological activity of CTGrade rh IL-6 was determined by its ability to stimulate the proliferation of B9 cells.
Technical Specifications***
Alternate Names | IFN-β2, B-cell Differentiation Factor, BSF-2, HSF, MGI-2 |
Accession Number | P05231 |
AA Sequence | MPVPPGEDSK DVAAPHRQPL TSSERIDKQI RYILDGISAL RKETCNKSNM CESSKEALAE NNLNLPKMAE KDGCFQSGFN EETCLVKIIT GLLEFEVYLE YLQNRFESSE EQARAVQMST KVLIQFLQKK AKNLDAITTP DPTTNASLLT KLQAQNQWLQ DMTTHLILRS FKEFLQSSLR ALRQM |
Predicted Molecular Mass | Monomer, 20.9 kDa (185aa) |
Formulation | CTGrade rh IL-6 lyophilized at 1 mg/ml in 10 mM Sodium Phosphate, pH 7.5, 0.2 µm filtered |
Protein Purity | ≥ 97% determined by reducing and non-reducing SDS-PAGE analysis |
Endotoxin | < 0.05 EU/µg using USP <85> / EP 2.6.14 |
Bioactivity | ED50 is determined by the dose-dependent proliferation of B9 cells. The ED50 is typically less than 0.025 ng/mL. The international units of CTGrade rh IL-6 is approximately 1.2 x106 IU/µg, which is calibrated against recombinant human interleukin 6 WHO International Standard (NIBSC code 89/548). |
Quality | Carrier-free and no animal- or human-derived materials were used during manufacturing |